Brought to you by

Astra buys out Merck's share of joint venture Astra Merck
02 Jul 2012
Executive Summary
Astra AB will gain full ownership of the 50/50 joint venture formed in 1994, Astra Merck Inc., between it and Merck & Co., in a deal which analysts predict may be worth a net present value of $7-10bn, depending on sales of the JV's products.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com